Verona pharma secures debt financing of up to $150 million from oxford finance

Non-dilutive capital finances planned launch of ensifentrine for copd non-dilutive capital finances planned launch of ensifentrine for copd
VRNA Ratings Summary
VRNA Quant Ranking